Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
INCR

Market Cap: $61.12M

IL

InterCure Ltd.

INCR

NASDAQ (NASDAQ Global Market)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin15.06%

EBITDA Margin-20.48%

EBIT Margin-24.89%

Pre-tax Margin-16.32%

Net Profit Margin-13.22%

Earnings Yield-21.83%

Valuation Multiples

Price / Book0.41

Price / Sales0.71

Price / Earnings-4.55

PEG-0.06

Forward PEG-0.06

EV / Sales1.21

EV / EBITDA-5.92

EV / Operating Cash Flow19.46

EV / Free Cash Flow24.66

Price / Free Cash Flow14.38

Price / Operating Cash Flow9.72

Cash Flow & Capital

Free Cash Flow / Share$1.31

Operating Cash Flow / Share$1.66

Free Cash Flow Yield6.95%

Capex / Revenue1.31%

Capex / Operating Cash Flow21.07%

Capex / Depreciation0.21

Stock Compensation / Revenue0.90%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio1.48

Quick Ratio0.97

Cash Ratio0.22

Debt / Assets0.27

Debt / Capital0.32

Debt / Equity0.46

Long-Term Debt / Capital0.13

Debt / Market Cap83.30%

Net Debt / EBITDA-2.47

Solvency Ratio-0.08

Financial Leverage1.74

Efficiency & Working Capital

Asset Turnover0.39

Fixed Asset Turnover2.63

Inventory Turnover2.12

Receivables Turnover1.75

Payables Turnover3.37

Days Sales Outstanding208.67

Days Inventory Outstanding171.87

Days Payables Outstanding108.38

Operating Cycle380.53

Cash Conversion Cycle272.16

Working Capital Turnover2.64

Returns & Quality

Return on Equity-8.63%

Return on Assets-5.17%

Return on Invested Capital-4.70%

ROCE-5.72%

Return on Tangible Assets-7.58%

Operating Return on Assets-3.95%

Income Quality-0.47

Tax Burden0.81

Interest Burden0.66

Balance Sheet & Intrinsic Metrics

Enterprise Value$327.74M

Invested Capital$424.39M

Working Capital$102.38M

Tangible Asset Value$177.17M

Net Current Asset Value$22.55M

Graham Net-Net-$7.66

Book Value / Share$39.1

Tangible Book Value / Share$17.48

Cash / Share$4.6

Financial Health Scores

Piotroski Score4

Altman Z-Score0.00

Revenue$270.2M

EBIT$-67.24M

Market Cap$193.21M

Working Capital$102.38M

Retained Earnings$-314.62M

Total Assets$690.55M

Total Liabilities$294.2M